INR 1319.3
(9.99%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 6.4 Billion INR | -49.67% |
2022 | 16.85 Billion INR | -10.94% |
2021 | 18.92 Billion INR | 1.12% |
2020 | 18.71 Billion INR | 6.8% |
2019 | 17.51 Billion INR | -16.11% |
2018 | 20.88 Billion INR | -10.29% |
2017 | 23.27 Billion INR | -5.97% |
2016 | 24.75 Billion INR | 0.13% |
2015 | 24.72 Billion INR | 6.9% |
2014 | 23.12 Billion INR | 5.87% |
2013 | 21.84 Billion INR | 15.34% |
2012 | 18.93 Billion INR | 21.7% |
2011 | 15.56 Billion INR | 19.85% |
2010 | 12.98 Billion INR | -28.84% |
2009 | 18.24 Billion INR | 20.33% |
2008 | 15.16 Billion INR | 70.06% |
2007 | 8.91 Billion INR | 26.64% |
2006 | 7.04 Billion INR | -12.87% |
2005 | 8.07 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.74 Billion INR | -24.02% |
2023 Q4 | 2.29 Billion INR | -43.03% |
2023 FY | 8.48 Billion INR | -49.67% |
2023 Q1 | 3.99 Billion INR | -2.21% |
2023 Q2 | 4.49 Billion INR | 12.53% |
2023 Q3 | 4.02 Billion INR | -10.47% |
2022 FY | 16.85 Billion INR | -10.94% |
2022 Q1 | 4.48 Billion INR | -0.87% |
2022 Q2 | 4.43 Billion INR | -1.12% |
2022 Q3 | 3.86 Billion INR | -12.87% |
2022 Q4 | 4.08 Billion INR | 5.7% |
2021 Q3 | 4.7 Billion INR | -1.47% |
2021 FY | 18.92 Billion INR | 1.12% |
2021 Q1 | 4.92 Billion INR | 13.59% |
2021 Q2 | 4.77 Billion INR | -3.05% |
2021 Q4 | 4.51 Billion INR | -3.84% |
2020 Q4 | 4.33 Billion INR | -6.08% |
2020 FY | 18.71 Billion INR | 6.8% |
2020 Q3 | 4.61 Billion INR | 2.27% |
2020 Q2 | 4.5 Billion INR | -9.69% |
2020 Q1 | 4.99 Billion INR | 72.91% |
2019 Q3 | 4.18 Billion INR | -4.47% |
2019 Q2 | 4.37 Billion INR | -2.24% |
2019 FY | 17.51 Billion INR | -16.11% |
2019 Q4 | 2.88 Billion INR | -30.94% |
2019 Q1 | 4.47 Billion INR | -16.8% |
2018 Q1 | 5.89 Billion INR | -5.11% |
2018 FY | 20.88 Billion INR | -10.29% |
2018 Q4 | 5.38 Billion INR | -10.84% |
2018 Q3 | 6.03 Billion INR | -3.43% |
2018 Q2 | 6.25 Billion INR | 5.98% |
2017 Q1 | 5.94 Billion INR | -7.04% |
2017 FY | 23.27 Billion INR | -5.97% |
2017 Q4 | 6.21 Billion INR | 12.99% |
2017 Q3 | 5.5 Billion INR | -4.88% |
2017 Q2 | 5.78 Billion INR | -2.72% |
2016 Q4 | 6.39 Billion INR | 6.49% |
2016 FY | 24.75 Billion INR | 0.13% |
2016 Q2 | 6.1 Billion INR | 0.33% |
2016 Q1 | 6.08 Billion INR | 5.9% |
2016 Q3 | 6 Billion INR | -1.58% |
2015 Q3 | 6.01 Billion INR | -8.21% |
2015 FY | 24.72 Billion INR | 6.9% |
2015 Q1 | 5.92 Billion INR | -19.69% |
2015 Q2 | 6.55 Billion INR | 10.54% |
2015 Q4 | 5.74 Billion INR | -4.51% |
2014 Q1 | 5.67 Billion INR | 1.29% |
2014 FY | 23.12 Billion INR | 5.87% |
2014 Q4 | 7.38 Billion INR | 37.08% |
2014 Q3 | 5.38 Billion INR | 15.41% |
2014 Q2 | 4.66 Billion INR | -17.81% |
2013 FY | 21.84 Billion INR | 15.34% |
2013 Q4 | 5.6 Billion INR | -0.46% |
2013 Q1 | 5.01 Billion INR | -7.77% |
2013 Q3 | 5.62 Billion INR | 6.17% |
2013 Q2 | 5.3 Billion INR | 5.77% |
2012 Q4 | 5.43 Billion INR | 8.9% |
2012 Q1 | 3.96 Billion INR | 23.93% |
2012 FY | 18.93 Billion INR | 21.7% |
2012 Q2 | 4.55 Billion INR | 14.95% |
2012 Q3 | 4.99 Billion INR | 9.57% |
2011 Q4 | 3.19 Billion INR | -13.45% |
2011 FY | 15.56 Billion INR | 19.85% |
2011 Q3 | 3.69 Billion INR | 0.0% |
2010 FY | 12.98 Billion INR | -28.84% |
2009 FY | 18.24 Billion INR | 20.33% |
2008 FY | 15.16 Billion INR | 70.06% |
2007 FY | 8.91 Billion INR | 26.64% |
2006 FY | 7.04 Billion INR | -12.87% |
2005 FY | 8.07 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 95.849% |
NATCO Pharma Limited | 10.05 Billion INR | 36.369% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -356.234% |
Syncom Formulations (India) Limited | 942.39 Million INR | -579.118% |
Achyut Healthcare Limited | 1.6 Million INR | -397662.585% |
Ajanta Pharma Limited | 30.46 Billion INR | 78.991% |
Alkem Laboratories Limited | 32.83 Billion INR | 80.509% |
Alpa Laboratories Limited | 156.14 Million INR | -3998.702% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 59.672% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | -146.116% |
Aurobindo Pharma Limited | 39.23 Billion INR | 83.688% |
Bajaj HealthCare Limited | 985.34 Million INR | -549.519% |
Bliss GVS Pharma Limited | 1.41 Billion INR | -350.951% |
Brooks Laboratories Limited | 51.18 Million INR | -12404.885% |
Divi's Laboratories Limited | 14.17 Billion INR | 54.834% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 93.325% |
Eris Lifesciences Limited | 4.94 Billion INR | -29.478% |
FDC Limited | 5.34 Billion INR | -19.659% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 90.528% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 45.02% |
Granules India Limited | 7.18 Billion INR | 10.893% |
Gufic Biosciences Limited | 1.07 Billion INR | -493.851% |
Hester Biosciences Limited | 908.84 Million INR | -604.194% |
Indoco Remedies Limited | 4.74 Billion INR | -34.772% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | -201.292% |
Ipca Laboratories Limited | 13.91 Billion INR | 54.006% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -727.504% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -13766.02% |
Lasa Supergenerics Limited | 291.17 Million INR | -2097.998% |
Laurus Labs Limited | 3.01 Billion INR | -112.568% |
Lupin Limited | 95.67 Billion INR | 93.311% |
Mankind Pharma Limited | 23.15 Billion INR | 72.358% |
Medicamen Biotech Limited | 335.16 Million INR | -1809.496% |
Medico Remedies Limited | 161.84 Million INR | -3854.425% |
Megasoft Limited | 49.52 Million INR | -12821.984% |
Piramal Pharma Limited | 19.91 Billion INR | 67.862% |
RPG Life Sciences Limited | 1.63 Billion INR | -291.318% |
Sigachi Industries Limited | 579.88 Million INR | -1003.663% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -108.008% |
Unichem Laboratories Limited | 6.72 Billion INR | 4.845% |
Wanbury Limited | 1.16 Billion INR | -451.284% |
Windlas Biotech Limited | 1 Billion INR | -535.861% |
ZIM Laboratories Limited | 1.01 Billion INR | -531.751% |
Zydus Lifesciences Limited | 43.17 Billion INR | 85.176% |
Procter & Gamble Health Limited | 2.99 Billion INR | -113.661% |
Amrutanjan Health Care Limited | 1.09 Billion INR | -482.354% |
Bal Pharma Limited | 389.89 Million INR | -1541.489% |
Strides Pharma Science Limited | 9.16 Billion INR | 30.149% |
Venus Remedies Limited | 1.91 Billion INR | -233.98% |
Aarti Pharmalabs Limited | 3.07 Billion INR | -108.171% |
Nectar Lifesciences Limited | 625.55 Million INR | -923.1% |
Shilpa Medicare Limited | 2.18 Billion INR | -193.499% |
Aarti Drugs Limited | 1.16 Billion INR | -448.19% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -482.454% |
Suven Life Sciences Limited | 109.75 Million INR | -5731.435% |
Ind-Swift Limited | 946.56 Million INR | -576.128% |
Valiant Laboratories Limited | 36.28 Million INR | -17536.198% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 23.964% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | -39.747% |
Themis Medicare Limited | 782.85 Million INR | -717.52% |
Hikal Limited | 2.48 Billion INR | -157.406% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 70.124% |
Sequent Scientific Limited | 2.9 Billion INR | -120.552% |
Novartis India Limited | 470.1 Million INR | -1261.412% |
Jubilant Pharmova Limited | 14.45 Billion INR | 55.722% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -39382.534% |
Neuland Laboratories Limited | 2.92 Billion INR | -118.449% |
Morepen Laboratories Limited | 1.98 Billion INR | -222.021% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -1451.79% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | -846.54% |